SubsidieMeestersInnovative, minimally invasive Medical Prostatic Retraction Device for the treatment of Benign Prostatic Hyperplasia (BPH) Patients in the office settings.
Butterfly Medical is developing a minimally invasive device for BPH treatment that enhances urine flow without surgery, aiming for post-marketing studies in Europe and pivotal FDA trials in the US.
Projectdetails
Introduction
Butterfly Medical, a medical-device start-up, is developing a fast, simple, and minimally invasive alternative treatment to medication and surgery used for Benign Prostate Hyperplasia (BPH) treatment. Butterfly’s innovative device transfers the procedure from the operating room to the clinic, with the device being placed in 6 to 8 minutes in a doctor’s office, under local anaesthesia.
Device Description
Butterfly’s unique anatomically shaped proprietary nitinol implant is positioned in the prostatic urethra in order to open the urine path in the prostate for improved urine flow, thereby relieving BPH symptoms. The implant doesn’t require any resection, cutting, or ablation of prostatic tissue.
Clinical Trials
FIH clinical trials involving 85 patients performed in leading medical centres in Israel show a high degree of safety and effectiveness.
Future Plans
Through this EIC project, Butterfly will undertake:
- Post-marketing studies in leading medical centres in Europe.
- A pivotal FDA study in the US.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.500.000 |
| Totale projectbegroting | € 4.823.931 |
Tijdlijn
| Startdatum | 1-9-2023 |
| Einddatum | 31-8-2025 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- BUTTERFLY MEDICAL LTDpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Advancing Transcatheter Mitral Valve RepairThe Mitral butterfly implant is a self-expanding device designed to stabilize the heart's posterior leaflet, enhancing coaptation and minimizing surgical complexity during delivery. | EIC Accelerator | € 2.499.999 | 2023 | Details |
Multi4 - the first surgical instrument for bladder cancer treatment through a 20-minute outpatient procedureMulti4 is developing an innovative surgical instrument for bladder cancer treatment that enables outpatient procedures, enhancing patient care and reducing recurrence rates. | EIC Accelerator | € 2.493.000 | 2024 | Details |
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes. | EIC Accelerator | € 2.306.500 | 2024 | Details |
Restoring a normal life and dignity for women and men suffering from severe Stress Urinary IncontinenceDeveloping UroActive™, a smart artificial urinary sphincter that offers a safe, convenient, and effective solution for severe urinary incontinence, minimizing side effects and restoring patient dignity. | EIC Accelerator | € 2.499.999 | 2023 | Details |
Minimally invasive suturing for vascular bore closure and heart defect repairNovelrad's NVCD closure device aims to minimize complications in large-bore vascular closures during cardiac surgeries through innovative micro-suturing technology, facilitating safer and faster procedures. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Advancing Transcatheter Mitral Valve Repair
The Mitral butterfly implant is a self-expanding device designed to stabilize the heart's posterior leaflet, enhancing coaptation and minimizing surgical complexity during delivery.
Multi4 - the first surgical instrument for bladder cancer treatment through a 20-minute outpatient procedure
Multi4 is developing an innovative surgical instrument for bladder cancer treatment that enables outpatient procedures, enhancing patient care and reducing recurrence rates.
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""
NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes.
Restoring a normal life and dignity for women and men suffering from severe Stress Urinary Incontinence
Developing UroActive™, a smart artificial urinary sphincter that offers a safe, convenient, and effective solution for severe urinary incontinence, minimizing side effects and restoring patient dignity.
Minimally invasive suturing for vascular bore closure and heart defect repair
Novelrad's NVCD closure device aims to minimize complications in large-bore vascular closures during cardiac surgeries through innovative micro-suturing technology, facilitating safer and faster procedures.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Photoacoustic imaging and artificial intelligence-based theranostic approach for cancerPHIRE aims to develop a novel theranostic device for high-resolution imaging and treatment of bladder cancer lesions under 1 mm, improving patient outcomes and reducing tumor relapse. | EIC Transition | € 2.084.871 | 2023 | Details |
MicroHeartHet project ontwikkelt een gestandaardiseerd productieproces voor de ELANA Heart Bypass, een minimaal-invasieve behandeling voor coronaire hartziekten, ter verbetering van patiëntenzorg en commercialisatie. | Mkb-innovati... | € 155.525 | 2018 | Details |
AI and Robotics for Prostate BiopsyThe ROBIOPSY project aims to develop a robotic prostate biopsy prototype for clinical trials, enhancing diagnostic accuracy and addressing health economics for improved cancer treatment. | EIC Transition | € 2.499.141 | 2023 | Details |
PROstate Focal THerapyThe PROFTH project aims to advance prostate cancer focal therapies by developing robotics and AI for precise ablation device positioning, enhancing treatment safety and efficacy. | ERC Proof of... | € 150.000 | 2024 | Details |
Ultra-tunable and Bio-stable Antibacterial Coating (UBAC)Preimure ontwikkelt een innovatieve antibacteriële coating voor implantaten om infecties te voorkomen, revisieoperaties te verminderen en de zorgkosten te verlagen. | Mkb-innovati... | € 20.000 | 2022 | Details |
Photoacoustic imaging and artificial intelligence-based theranostic approach for cancer
PHIRE aims to develop a novel theranostic device for high-resolution imaging and treatment of bladder cancer lesions under 1 mm, improving patient outcomes and reducing tumor relapse.
MicroHeart
Het project ontwikkelt een gestandaardiseerd productieproces voor de ELANA Heart Bypass, een minimaal-invasieve behandeling voor coronaire hartziekten, ter verbetering van patiëntenzorg en commercialisatie.
AI and Robotics for Prostate Biopsy
The ROBIOPSY project aims to develop a robotic prostate biopsy prototype for clinical trials, enhancing diagnostic accuracy and addressing health economics for improved cancer treatment.
PROstate Focal THerapy
The PROFTH project aims to advance prostate cancer focal therapies by developing robotics and AI for precise ablation device positioning, enhancing treatment safety and efficacy.
Ultra-tunable and Bio-stable Antibacterial Coating (UBAC)
Preimure ontwikkelt een innovatieve antibacteriële coating voor implantaten om infecties te voorkomen, revisieoperaties te verminderen en de zorgkosten te verlagen.